ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sumitomo Dainippon publishes positive results of schizophrenia drug
July 23, 2019Japanese pharma company Sumitomo Dainippon has announced its drug Lonasen (blonanserin) has achieved its primary endpoint in a Phase III trial of 150 adolescents with schizophrenia. -
Poxel, Sumitomo Dainippon's experimental type 2 diabetes drug imeglimin meets main goal of Phase III study
April 10, 2019Poxel and Sumitomo Dainippon Pharma on Tuesday announced that the investigational type 2 diabetes treatment…… -
Sumitomo Dainippon announces good results from trial of its lead drug
January 14, 2019Japan-based Sumitomo Dainippon Pharma has published positive results from the phase III JEWEL trial into its drug Latuda (lurasidone hydrochloride) for patients with schizophrenia.....
Pharma Sources Insight January 2025
